Terms: = Head and neck cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
36 results:
1. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal cancer.
Hiroshima Y; Ishikawa H; Sumiya T; Murakami M; Nakamura M; Ishida T; Ogawa K; Hisakura K; Mizumoto M; Oda T; Okumura T; Sakurai H
In Vivo; 2023; 37(3):1253-1259. PubMed ID: 37103111
[TBL] [Abstract] [Full Text] [Related]
3. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
4. PARP5B is required for nonhomologous end joining during tumorigenesis in vivo.
Wu J; Crowe DL
Mol Carcinog; 2022 Jan; 61(1):85-98. PubMed ID: 34710250
[TBL] [Abstract] [Full Text] [Related]
5. MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner.
Wang YY; Chen YK; Lo S; Chi TC; Chen YH; Hu SC; Chen YW; Jiang SS; Tsai FY; Liu W; Li RN; Hsieh YC; Huang CJ; Yuan SF
Oncogene; 2021 May; 40(20):3510-3532. PubMed ID: 33927349
[TBL] [Abstract] [Full Text] [Related]
6. Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber cancer Institute, 2011 to 2019.
Xu Y; Wen N; Sonis ST; Villa A
Cancer; 2021 Jun; 127(11):1796-1804. PubMed ID: 33595843
[TBL] [Abstract] [Full Text] [Related]
7. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract] [Full Text] [Related]
8. treatment for benign thyroid nodules with a combination of natural extracts.
Stancioiu F; Mihai D; Papadakis GZ; Tsatsakis A; Spandidos DA; Badiu C
Mol Med Rep; 2019 Sep; 20(3):2332-2338. PubMed ID: 31322200
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
Li D; Ye L; Lei Y; Wan J; Chen H
BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
[TBL] [Abstract] [Full Text] [Related]
10. 4β-Hydroxywithanolide E selectively induces oxidative DNA damage for selective killing of oral cancer cells.
Tang JY; Huang HW; Wang HR; Chan YC; Haung JW; Shu CW; Wu YC; Chang HW
Environ Toxicol; 2018 Mar; 33(3):295-304. PubMed ID: 29165875
[TBL] [Abstract] [Full Text] [Related]
11. Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.
Yélamos O; Cordova M; Blank N; Kose K; Dusza SW; Lee E; Rajadhyaksha M; Nehal KS; Rossi AM
JAMA Dermatol; 2017 Dec; 153(12):1278-1284. PubMed ID: 29049429
[TBL] [Abstract] [Full Text] [Related]
12. Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Xu Y; Wang X; Chen SM; Chen C; Wang Y; Xiao BK; Tao ZZ
Am J Otolaryngol; 2016; 37(6):552-558. PubMed ID: 27726944
[TBL] [Abstract] [Full Text] [Related]
13. Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid cancer.
Marano F; Argenziano M; Frairia R; Adamini A; Bosco O; Rinella L; Fortunati N; Cavalli R; Catalano MG
Thyroid; 2016 May; 26(5):705-16. PubMed ID: 26906083
[TBL] [Abstract] [Full Text] [Related]
14. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.
Tonsing-Carter E; Bailey BJ; Saadatzadeh MR; Ding J; Wang H; Sinn AL; Peterman KM; Spragins TK; Silver JM; Sprouse AA; Georgiadis TM; Gunter TZ; Long EC; Minto RE; Marchal CC; Batuello CN; Safa AR; Hanenberg H; Territo PR; Sandusky GE; Mayo LD; Eischen CM; Shannon HE; Pollok KE
Mol Cancer Ther; 2015 Dec; 14(12):2850-63. PubMed ID: 26494859
[TBL] [Abstract] [Full Text] [Related]
15. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract] [Full Text] [Related]
16. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.
Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N
Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085
[TBL] [Abstract] [Full Text] [Related]
17. Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures.
Rossow L; Eke I; Dickreuter E; Cordes N
Oncol Rep; 2015 Jul; 34(1):469-76. PubMed ID: 26004008
[TBL] [Abstract] [Full Text] [Related]
18. RNF8 plays an important role in the radioresistance of human nasopharyngeal cancer cells in vitro.
Wang M; Chen X; Chen H; Zhang X; Li J; Gong H; Shiyan C; Yang F
Oncol Rep; 2015 Jul; 34(1):341-9. PubMed ID: 25955491
[TBL] [Abstract] [Full Text] [Related]
19. Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
Yossi S; Linot B; Peyraga G; Breheret R; Laccourreye L; Capitain O
Int J Clin Oncol; 2015 Dec; 20(6):1086-92. PubMed ID: 25931315
[TBL] [Abstract] [Full Text] [Related]
20. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway.
Li H; Chen X; Yu Y; Wang Z; Zuo Y; Li S; Yang D; Hu S; Xiang M; Xu Z; Yu Z
Oncol Rep; 2014 Dec; 32(6):2596-604. PubMed ID: 25333332
[TBL] [Abstract] [Full Text] [Related]
[Next]